Skip to main content

Table 1 Characteristics of the subjects and laboratory parameters at the time of the trial performance

From: Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden

Parameter Controls (N = 25) Patients (N = 41) p
Age (years) 42.2 (4.9) 44.8 (5.4) ns
BMI (kg/m2) 25.4 (3.4) 27.3 (2.7) 0.02
Waist-hip ratio (rel.) 0.93 (0.04) 0.94 (0.05) ns
Systolic blood pressure (mmHg) 133 (13) 125 (14) 0.02
Diastolic blood pressure (mmHg) 87 (11) 82 (10) ns
Total cholesterol (mmol/l) 4.99 (0.78) 4.55 (1.0) ns
LDL-cholesterol (mmol/l) 3.11 (0.73) 2.6 (0.87) 0.02
HDL-cholesterol (mmol/l) 1.18 (0.26) 1.02 (0.28) 0.02
TG (mmol/l) 1.50 (0.57) 2.18 (1.57) 0.04
Blood glucose (mmol/l) 5.4 (1.3) 5.9 (1.7) ns
Smokers (N) 4 (16%) 11 (27%) ns
Ex-smokers (N) 4 (16%) 23 (56%) <0.01
Family history (N) 2 (8%) 14 (34%) 0.01
  1. Values are shown as means and standard deviations; p-for the difference between the two groups, ns-not significant, N-number, BMI-body mass index, rel.-relative, LDL-low density cholesterol, HDL-high density cholesterol, TG-triglycerides.